Sponsor Dossier

AFT Pharmaceuticals

Sponsor Dossier for AFT Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

AFT Pharmaceuticals is an Australian Private Company with ABN 29105636413, registered in NSW. The company is currently active on the Australian Business Register.

Portfolio

AFT Pharmaceuticals maintains 106 brands on the ARTG, of which 59 are indexable. The company has 58 brands with Product Information on file, 8 brands with at least one PBS-listed item, and 6 brands with PBAC outcome records. No brands currently have AusPARs on record.

Therapeutic focus

AFT Pharmaceuticals' portfolio spans the following therapeutic areas: — Infectious Disease: 14 brands — Pain & Anaesthesia: 12 brands — Gastroenterology: 11 brands — Oncology: 10 brands — Neurology: 9 brands — Dermatology: 9 brands — Ophthalmology: 7 brands — Haematology: 7 brands — Complementary Medicine: 7 brands — Cardiology: 6 brands — Respiratory: 5 brands — Urology: 2 brands — Pain Management: 2 brands — Psychiatry: 1 brand — Reproductive Health: 1 brand — Women's Health: 1 brand — Other: 1 brand — Uncategorised: 1 brand

PBS footprint

AFT Pharmaceuticals has 8 brands with at least one PBS-listed item. The latest PBS schedule date the portfolio touched is 1 May 2026.

Regulatory activity

AFT Pharmaceuticals has 6 brands with PBAC outcomes on record, with the most recent PBAC outcome dated 1 July 2025.

ABR record